Healthcare technology titan Philips partners with Exor N.V.

Exor N.V. has acquired a 15% shareholding in Royal Philips for a US$2.8bn investment, in a move which will improve the health and well-being of customers

Global health technology leader Royal Philips has begun a business relationship with diversified Dutch holding company, Exor N.V.. Exor has brought a 15% shareholding in Philips for US$2.8bn. 


Strategic alliance between global health technology & holding company

Exor N.V. is among Europe’s biggest diversified holding companies and is the investment part of Italy's Agnelli family, with a Net Asset Value of around €34bn and a portfolio including Ferrari, Stellantis, CNH Industrial, Juventus FC, Iveco Group, The Economist, GEDI Gruppo Editoriale and SHANG XIA.

For 130 years, Philips has been helping people to live healthier lives, from building medical imaging systems to providing respiratory care. 

In the last decade, the company has evolved to become a leader in health technology and its new business relationship with Exor will ‘provide stable and committed support for long-term value creation’ plans. 

The relationship agreement includes:

  • Exor’s commitment to be a long-term minority investor 
  • The right to propose one member to the Supervisory Board
  • At Exor’s discretion, it will increase its participation to a maximum limit of 20% of Philips’ outstanding ordinary share capital.

A business relationship built on healthcare and technology

The Royal Philips leadership team is looking forward to seeing where the business relationship with Exor will take them.

“Exor’s investment in Philips, their long-term outlook and increased focus on healthcare and technology, fit well with our strategy and substantial value creation potential,” said Roy Jakobs, CEO of Royal Philips. “With our market leadership positions and people-centric innovation capabilities, Philips is well positioned to deliver on our purpose to improve the health and well-being of people, creating value for all stakeholders.”

“We welcome Exor as a long-term investor in Philips,” said Feike Sijbesma, Chairman of the Supervisory Board of Royal Philips. “They have a successful track record and clear strategy to grow and develop in healthcare and technology. Exor’s substantial investment underlines their confidence in Philips’ transformation into a healthcare technology company and its growth and value potential.”


For more insights into Healthcare - check out the latest edition of Healthcare Digital and be sure to follow us on LinkedIn & Twitter.

Other magazines that may be of interest - Manufacturing Magazine.


BizClik is a global provider of B2B digital media platforms that cover 'Executive Communities' for CEO's, CFO's, CMO's, Sustainability Leaders, Procurement & Supply Chain Leaders, Technology & AI Leaders, Cyber Leaders, FinTech & InsurTech Leaders as well as covering industries such as Manufacturing, Mining, Energy, EV, Construction, Healthcare + Food & Drink.

BizClik, based in London, Dubai & New York offers services such as Content Creation, Advertising & Sponsorship Solutions, Webinars & Events.


Featured Articles

Pi Labs’ Faisal Butt on transforming urban health technology

Faisal Butt, Founder & Managing Partner of Pi Labs, explores the technology used in urban healthcare, the growth of PropTech & digital transformation

Doceree secures US$35m in Series B Funding, led by Creaegis

Doceree’s technology-driven healthcare professional marketing expands with US$35m in Series B funding, led by Creaegis, to advance the sector globally

Honeywell comments on post-pandemic air quality challenges

Honeywell’s Sarah James calls for air sensors to ensure good air quality & Stefano D’Agostino explores how technology can help improve indoor air quality

Oracle's generative AI prioritises patient healthcare

Technology & AI

2San's new app provides vital diagnostic product insights

Technology & AI

Cylera’s Richard Staynings on healthcare cybersecurity

Technology & AI